Juvenescence Ltd - Feb 16, 2023 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Director, 10%+ Owner
Signature
/s/ Gregory Bailey, Executive Chairman of Juvenescence Ltd.
Stock symbol
AGE
Transactions as of
Feb 16, 2023
Transactions value $
$0
Form type
4
Date filed
2/17/2023, 06:01 AM
Previous filing
Feb 8, 2023
Next filing
Mar 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Warrant to Purchase Common Stock Award $0 +802K $0.00 802K Feb 16, 2023 Common Stock 802K $0.62 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Warrants issued in connection with the draw of loan funds under an Amended and Restated Secured Convertible Promissory Note between the issuer and the reporting person.
F2 The warrants are exercisable for shares of the issuer's common stock upon issuance.

Remarks:

Director by deputization